Hanall Biopharma Reports Operating Profit of 1.6 Billion KRW in Q2, Down 76.5% YoY

[Asia Economy Reporter Eunmo Koo] HanAll Biopharma announced on the 29th that its operating profit for the second quarter of this year was tentatively estimated at 1.638 billion KRW, a 76.5% decrease compared to the same period last year. During the same period, sales amounted to 22.601 billion KRW, down 24.2%, and net profit also decreased by 31.5% to 2.857 billion KRW.

This content was produced with the assistance of AI translation services.